Published • loading... • Updated
Fifth Circuit to hear Louisiana challenge to mail-order abortion pills
- Louisiana is challenging the FDA's 2023 removal of the in-person dispensing requirement for mifepristone, allowing it to be prescribed remotely and mailed, in a case set for the U.S. Fifth Circuit Court of Appeals on September 9.
- About a thousand abortions occur monthly in Louisiana through mail-order drugs, highlighting concerns over the drug's distribution.
- Louisiana Solicitor General Benjamin Aguinaga argued that reinstating the in-person requirement would reduce the ability of doctors in other states to prescribe and send mifepristone into Louisiana.
- On May 1, the Fifth Circuit temporarily suspended the 2023 FDA dispensing rules, siding with Louisiana and indicating the state was likely to prevail in its challenge.
Insights by Ground AI
34 Articles
34 Articles
Fifth Circuit to hear Louisiana challenge to mail-order abortion pills
(The Center Square) — Louisiana's effort to keep mail-order abortion pills out of the state is headed back to a federal appeals court next month, with the legal fight potentially affecting how mifepristone is distributed nationwide.
U.S. Fifth Circuit Court of Appeals issues stay against mail-order access to abortion pill
BATON ROUGE - A three-judge panel for the U.S. Fifth Circuit Court of Appeals ruled in favor of Louisiana and issued a stay preventing access to the abortion pill Mifepristone by mail across the U.S.
·Baton Rouge, United States
Read Full ArticleCoverage Details
Total News Sources34
Leaning Left4Leaning Right11Center17Last UpdatedBias Distribution53% Center
Bias Distribution
- 53% of the sources are Center
53% Center
13%
C 53%
R 34%
Factuality
To view factuality data please Upgrade to Premium
